Arkolith/Insider Trading/KROS/Form 4

Schneeberger Daniel

10% OwnerKeros Therapeutics, Inc. (KROS) · full profile →Form 4 · filed Jun 24, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Option exercise(X)1K$70.00$98K4.4M
Jun 20, 2025Option exercise(X)100$60.00$6K4.4M
Jun 20, 2025Option exercise(X)200$70.00$14K743K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2025Option exercise(X)1—$00
Jun 20, 2025Option exercise(X)14—$00
Jun 20, 2025Option exercise(X)2—$00

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-062092) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML